With 1 in 10 Americans saying they misuse drugs, doctors should ask everyone about both illegal and prescription use, the U.S. Preventive Services Task Force said

Quick Read

They tried to warn us about the dangers of OxyContin. Almost two decades later, we’re finally listening

Quick Read

Lou Ortenzio was a trusted West Virginia doctor who got his patients—and himself—hooked on opioids. Now he’s trying to rescue his community from an epidemic he helped start

Quick Read

Google parent company Alphabet Inc.’s experimental health-care unit Verily plans to partner with hospitals in Ohio, one of the states hardest-hit by the U.S. opioid epidemic, on a tech-heavy approach to treating people with substance-abuse disorders

Quick Read

New tool helps public health officials determine the scope of the opioid crisis in their communities. Rural communities have been in dire need of a means to estimate the number of people who inject drugs

Quick Read

How the Americans With Disabilities Act could change the way the nation’s jails and prisons treat addiction. Most jails and prisons around the country forbid methadone and a newer addiction medication, buprenorphine, even when legitimately prescribed, on the grounds that they pose safety and security concerns

Quick Read

Despite the mounting death toll of America’s opioid crisis, most facilities that treat substance use disorders don’t offer patients buprenorphine, naltrexone, or methadone—the three medications approved by the FDA for the long-term management of opioid use disorder, according to a new study

Quick Read

A filing in a Massachusetts lawsuit contains dozens of internal Purdue Pharma documents suggesting the family was far more involved than the company has long contended

Quick Read